-
Loading metrics
Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis
- Chiara Parravicini,
- Davide Lecca,
- Davide Marangon,
- Giusy Tindara Coppolino,
- Simona Daniele,
- Elisabetta Bonfanti,
- Marta Fumagalli,
- Luca Raveglia,
- Claudia Martini,
- Elisabetta Gianazza
x
- Published: April 22, 2020
- https://doi.org/10.1371/journal.pone.0231483